Jack Li

Jack Li is an experienced clinical pharmacologist with a strong track record in driving clinical trials and advancing pharmacometric research. Since October 2018, Jack has held the position of Executive Director of Clinical Pharmacology at Gossamer Bio, previously serving as Senior Director in the same field. Prior to this, Jack was the Director of Quantitative Clinical Pharmacology & Translational Science at Daiichi Sankyo, Inc. between July 2015 and October 2018, and held the Director position at Ambit Biosciences Corporation from August 2010 to July 2015. Jack's early career includes significant roles at Phenomix Corporation and Pfizer, where contributions spanned areas such as pharmacokinetics, pharmacodynamics, and drug metabolism. Educational qualifications include attendance at UC San Diego from 1990 to 1996.